MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma.
Talati P, El-Abtah M, Kim D, Dietrich J, Fu M, Wenke M, He J, Natheir SN, Vangel M, Rapalino O, Vaynrub A, Arrillaga-Romany I, Forst DA, Yen YF, Andronesi O, Kalpathy-Cramer J, Rosen B, Batchelor TT, Gonzalez RG, Gerstner ER, Ratai EM.
Talati P, et al. Among authors: rosen b.
Neurooncol Adv. 2021 Apr 15;3(1):vdab060. doi: 10.1093/noajnl/vdab060. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 34131648
Free PMC article.